Feed Insights Top Reports Pricing

⌘K

09:00:58·819d

SECFilingvia Quantisnow

SEC Form 10-K/A filed by CRH PLC (Amendment)

ByQuantisnow·Wall Street's wire, on your screen.

Industrials

Plus alert sent

Quantisnow Plus members were alerted at 09:00:59 ET - 1.3s after publication.

Sign up for Plus

Free Quantisnow account

Get notified the moment CRH files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRH (CRH PLC) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

CRH appoints Danilo Juvane as Head of Investor Relations
CRH PLC filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
Officer Oriordain Padraig sold $155,832 worth of Ordinary Shares (1,492 units at $104.45), decreasing direct ownership by 55% to 1,205 units (SEC Form 4)
SEC Form 4 filed by CRH PLC
Director Verchere Christina Campbell converted options into 2,004 units of Ordinary Shares and covered exercise/tax liability with 962 units of Ordinary Shares, increasing direct ownership by 104% to 2,042 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022